MyoKardia (MYOK) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free MYOK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCytokinetics: CEO Talks Down Buyout Prospectsseekingalpha.com - March 16 at 7:08 AMQ4 2023 Fulcrum Therapeutics Inc Earnings Calluk.finance.yahoo.com - February 27 at 11:26 PMFulcrum Therapeutics Inc (FULC) Reports Financial Results for Q4 and Full Year 2023finance.yahoo.com - February 27 at 8:22 AMFulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023markets.businessinsider.com - February 27 at 8:22 AMIf heart disease runs in your family, talk to your doctor about HCMcbsnews.com - February 16 at 10:23 AMBristol Myers pours $100M into RNA drugs for cardiovascular diseasesfinance.yahoo.com - November 29 at 2:39 PMAvidity and BMS enter $2.3bn deal for cardiovascular targetsmsn.com - November 29 at 2:39 PMWhy Is RNA Therapeutics-Focused Avidity Biosciences Stock Trading Higher Today?msn.com - November 28 at 2:17 PMAvidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone paymentsmsn.com - November 28 at 9:17 AMHow Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Fasterforbes.com - November 22 at 9:22 AMWhy LianBio Stock Is Ripping Higher Todaybenzinga.com - October 24 at 2:17 PMWhy Is LianBio (LIAN) Stock Up 130% Today?msn.com - October 24 at 2:17 PMWhy LianBio Stock Is Skyrocketing Todaymsn.com - October 24 at 2:17 PMLianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Marketsfinance.yahoo.com - October 24 at 8:11 AMBristol Myers (BMY) to Acquire Mirati Therapeutics for $5.8 Bmsn.com - October 9 at 12:59 PMPeninsula biotech company looks to pump new life into heart disease treatmentsbizjournals.com - October 4 at 6:08 PMFulcrum Therapeutics (FULC) Price Target Increased by 30.97% to 10.78msn.com - August 31 at 7:11 PMCutera, Inc. Appoints Taylor Harris as Chief Executive Officerfinance.yahoo.com - July 27 at 10:44 AMCutera Names Taylor Harris As CEO, Shares Gainmarkets.businessinsider.com - July 27 at 10:44 AMCutera Names Taylor Harris CEO, Ending Succession Tussle >CUTRmarketwatch.com - July 27 at 10:44 AMAbivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directorsfinance.yahoo.com - July 11 at 2:00 PMEQS-News: Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directorsmarkets.businessinsider.com - July 11 at 2:00 PMKorporatsiya VSMPO AVISMA PAO (VSMO)investing.com - July 10 at 9:39 PMHypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2023uk.finance.yahoo.com - June 9 at 4:12 PM3 Dividend Stocks You Can Buy Without Any Hesitationmsn.com - June 3 at 8:41 AMTenaya Therapeutics, Inc.: Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - May 11 at 11:05 PMLianBio Announces Marketing Approval of CAMZYOS(R) (mavacamten) in the Macau Special Administrative Region (SAR) of Chinamarketwatch.com - May 11 at 11:05 PMTenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updatetechnews.tmcnet.com - May 10 at 5:03 PMDiabetes Drug Therapy Market Analysis Report focuses on the remarkable market size CAGR rate of 4.6% for period from 2023 and 2030.marketwatch.com - April 13 at 2:03 PMBrain Ischemia market research report will assist market stakeholders in analysing the growing CAGR of 5.1% to make more informed decisions.marketwatch.com - April 13 at 8:57 AMThe report on the Potassium Channel Blocker market assesses the competition, their advantages, and drawbacks, and predicts a CAGR of 5.3% by 2030.marketwatch.com - April 9 at 12:18 PMREGENCOR EXPANDS SCIENTIFIC ADVISORY BOARDbenzinga.com - March 24 at 1:47 PMCytokinetics heart failure drug turned back by FDAbizjournals.com - March 3 at 6:14 PMDilated Cardiomyopathy Therapeutics Market Size, Share and Forecast 2028 with Top Countries Datamarketwatch.com - February 24 at 4:41 AMDilated Cardiomyopathy Therapeutics Market 2023: Growth Outlook and Forecast 2027 with Top Leaders, Size and Share Analysismarketwatch.com - February 6 at 1:50 PMMaze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chief Medical Officer - Yahoo Financefinance.yahoo.com - October 13 at 4:20 PMMaze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chie - Benzingabenzinga.com - October 13 at 10:40 AMGot $5,000? These 2 Stocks Could Continue Beating the Bear Market. - Nasdaqnasdaq.com - October 12 at 1:06 PMBristol-Myers Squibb: A Gem Amid Macroeconomic Uncertainties - Seeking Alphaseekingalpha.com - October 2 at 10:18 AMArthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures - StreetInsider.comstreetinsider.com - September 27 at 11:03 AMBristol Myers Squibb Stock: Still A Buy Despite Some Concerns (NYSE:BMY) - Seeking Alphaseekingalpha.com - September 11 at 8:17 AMSonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer - StreetInsider.comstreetinsider.com - September 8 at 2:31 AMSonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer - Yahoo Financefinance.yahoo.com - September 7 at 4:30 PMAristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer - Yahoo Financefinance.yahoo.com - August 24 at 6:38 PMSimcha Therapeutics Accelerates Growth with Key Leadership Appointments, Expanded Research and Option Agreement with Yale School of Medicine - Business Wirebusinesswire.com - August 18 at 4:58 AMBristol Myers Squibb: Keep Buying On Good Performance (NYSE:BMY) - Seeking Alphaseekingalpha.com - August 12 at 6:10 PMLianBio Completes Enrollment in Pivotal Phase 3 EXPLORER-CN Trial of Mavacamten in Chinese Obstructive Hypertrophic Cardiomyopathy Patients - Yahoo Financefinance.yahoo.com - August 10 at 6:24 PMLianBio Completes Enrollment in Pivotal Phase 3 EXPLORER-CN Trial of Mavacamten in Chinese Obstructive Hypertrophic Cardiomyopathy Patients - GlobeNewswireglobenewswire.com - August 10 at 1:23 PMFamed "Big Short" Investor Loves This Multibillion-Dollar Company -- Should You? - The Motley Foolfool.com - August 3 at 10:18 AMTerns Pharmaceuticals Inc. (TERN) Appoints Radhika Tripuraneni to its Board - StreetInsider.comstreetinsider.com - July 27 at 6:21 PM Get MyoKardia News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy MYOK Media Mentions By Week MYOK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYOK News Sentiment▼0.000.62▲Average Medical News Sentiment MYOK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYOK Articles This Week▼10▲MYOK Articles Average Week Get MyoKardia News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KRTX News Today UTHR News Today SRPT News Today RDY News Today LEGN News Today CTLT News Today VTRS News Today ASND News Today TEVA News Today BGNE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYOK) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaThe world’s greatest investmentPorter & CompanyBiden out June 13?Paradigm PressMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyoKardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.